Georg Beilhack
Overview
Explore the profile of Georg Beilhack including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Razazian M, Bahiraii S, Jannat I, Tiffner A, Beilhack G, Levkau B, et al.
Pflugers Arch
. 2025 Feb;
PMID: 39899071
Medial vascular calcification is common in chronic kidney disease patients and linked to hyperphosphatemia. Upon phosphate exposure, intricate signaling events orchestrate pro-calcific effects in the vasculature mediated by vascular smooth...
2.
Beilhack G, Monteforte R, Frommlet F, Reindl-Schwaighofer R, Strassl R, Vychytil A
Vaccines (Basel)
. 2023 Jun;
11(6).
PMID: 37376510
Anti-SARS-CoV-2 vaccination of dialysis patients has been proven to be safe and effective to reduce COVID-19-related morbidity and mortality. However, data on the durability of anti-SARS-CoV-2 antibodies post-vaccination in peritoneal...
3.
Beilhack G, Monteforte R, Frommlet F, Reindl-Schwaighofer R, Strassl R, Vychytil A
Front Med (Lausanne)
. 2022 Jul;
9:905798.
PMID: 35814775
In dialysis patients the humoral response to anti-SARS-CoV-2 vaccines is attenuated and rapidly declines over time. However, data on the persistence of the immune response in peritoneal dialysis (PD) patients...
4.
Beilhack G, Monteforte R, Frommlet F, Gaggl M, Strassl R, Vychytil A
Front Immunol
. 2021 Dec;
12:780594.
PMID: 34925359
Background: Dialysis patients are at high risk for a severe clinical course after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Safety and early immune responses after mRNA-based vaccination...
5.
Beilhack G, Lindner G, Funk G, Monteforte R, Schwarz C
Swiss Med Wkly
. 2020 Nov;
150:w20366.
PMID: 33181857
Background: Acid base and electrolyte disorders are frequently reported in the early period after renal transplantation. No comprehensive data exist on the prevalence and patterns of, and contributing factors to,...
6.
Winnicki W, Pichler P, Mechtler K, Imre R, Steinmacher I, Sengolge G, et al.
PeerJ
. 2019 Dec;
7:e8218.
PMID: 31871840
Background: Complement factor C3 represents the central component of the complement cascade and its activation split product C3a plays an important role in inflammation and disease. Many human disorders are...
7.
Chung B, Stuge T, Murad J, Beilhack G, Andersen E, Armstrong B, et al.
Cell Rep
. 2014 Aug;
8(3):871-882.
PMID: 25088413
Current vaccine conditions predominantly elicit low-avidity cytotoxic T lymphocytes (CTLs), which are non-tumor-cytolytic but indistinguishable by tetramer staining or enzyme-linked immunospot from high-avidity CTLs. Using CTL clones of high or...
8.
Hecking M, Kainz A, Bielesz B, Plischke M, Beilhack G, Horl W, et al.
Clin Biochem
. 2012 Dec;
45(18):1645-51.
PMID: 23217247
Objectives: In chronic kidney disease-mineral and bone disorder (CKD-MBD), most treatment decisions are guided by parathyroid hormone (PTH) levels. Here, we aimed at assessing the technical and clinical performance of...